3Kato A,Shimizu H,Ohtsuka M,et al.Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single- center study[J].Ann Surg Oncol,2013,20(1 ):318-324.
4Thongprasert S. The role of chemotherapy in cholan- giocarcinoma[J].Ann Oncol,2005,16(S1 2):ii93-ii96.
5Park J S,Oh S Y,Kim S H,et al. Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase Ⅱ study[J].Jpn J Clin 0ncol,2005,35(2):68-73.
6Furuse J,Okusaka T, Boku N,et al.S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase Ⅱ study [J ].Cancer Chemo- ther Pharmacol,2008,62 (5) :849-855.
7Valle J,Wasan H,Palmer D H,et al.Cisplatin plus gemci- tabine versus gemcitabine for biliary tract cancer [J].N Engl J Med,2010,362(14) : 1273-1281.
8Roth J A,Carlson J J.Cost-effectiveness of gemcitabine + cisptatin vs. gemcitabine monotherapy in advanced biliary tract cancer [J].J Gastrointest Cancer,2012,43 (2):215- 223.
9Andre T,Toumigand C,Rosmorduc O,et at.Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma:a GERCOR study [J].Ann Oncol, 2004,15(9):1339-1343.
10Hollebecque A,Bouch60,Romano O,et al.Experience of gemeitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma [J].Chemotherapy, 2010,56(3):234-238.
二级参考文献67
1Takashi Sasaki,Hiroyuki Isayama,Yousuke Nakai,Naminatsu Takahara,Naoki Sasahira,Hirofumi Kogure,Suguru Mizuno,Hiroshi Yagioka,Yukiko Ito,Natsuyo Yamamoto,Kenji Hirano,Nobuo Toda,Minoru Tada,Masao Omata,Kazuhiko Koike.Improvement of prognosis for unresectable biliary tract cancer[J].World Journal of Gastroenterology,2013,19(1):72-77. 被引量：8
3Shuichi Miyakawa, Shin Ishihara, Tadahiro Takada, et al, Flowcharts for the management of biliary tract and ampullary carcinomas [J]. J Hepatobiliary Pancreat Surg, 2008,15(1): 7-14.
4Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chem?otherapy useful for gallbladder carcinoma? A phase ill multicenter prospective randomized controlled trial in patients with resected pan?creaticobiliary carcinoma[J]. Cancer, 2002,95(8): 1685-1695.
5Bernard Paule, Paola Andreani, Marie-Pierre Bralet, et al, Adjuvant gemcitabine-oxaliplatin (GEMme) after curative surgery in high-risk patients with cholangiocarcinoma [J]. Clin Med Oncol, 2009, (3): 121-126.
6Jarnagin W, Fong Y, DeMatteo RP, et a1. Staging, resectability, and outcome in 225 patients with hilar angiocarcinoma [J]. Ann Surg, 2001,234(4):507-519.
7Patt YZ, Jones DV, Jr, Hoque A, et a1. Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract can?cer[J]. J Clin Oncol, 1996,(51):515-517.
8Falkson G, Mancintyre JM, Moertel, et al, Eastern Cooperative Oncol?ogy Group experience with chemotherapy for inoperable gallbladder and bile duct cancer[J]. Cancer, 1984,(54):965-969.
9Rougier P, Fandi A. Ducreux M, et al. Demonstrated effiiciency of 5-FU continuous infusion and cisplatin in patients with advanced bil?iary tract carcinoma. Proc Am Soc Clin Oncol, 1995,14: 205.
10Gebbia V, Majello E,Testa A,et a1.Treatrnent of advanced adenocarci?nomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Result ofa multicenter study of the Southern Italy Oncology Group (G.O.I.M)[J]. Cancer, 1996,78:1300-1307.
